Mylan NV Ord Shs (MYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYL | RDY | BBIO | ||
| Company | Mylan NV Ord Shs | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 15.64 | 71.43 | 25.37 | ||
| High | 16.15 | 71.63 | 25.78 | ||
| Low | 15.34 | 70.78 | 24.44 | ||
| Last | 15.86 | 70.92 | 25.03 | ||
| Change | +0.31 | -0.57 | -0.43 | ||
| % Change | +1.96% | -0.80% | -1.69% | ||
| Volume | 26,574,100 | 149,246 | 1,540,200 | ||
| 20-Day Average Volume | 8,612,350 | 163,055 | 1,608,985 | ||
| Previous Close | 15.55 | 71.49 | 25.46 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.15 | 72.40 | 27.33 | ||
| 20-Day Raw Stochastic | 86.27% | 5.50% | 12.61% | ||
| 20-Day Relative Strength | 55.75% | 41.34% | 36.08% | ||
| Weighted Alpha | -23.10 | +15.01 | -6.84 | ||
| Today's Opinion | 40% Sell | 24% Buy | 88% Sell | ||
| Previous Opinion | 64% Sell | 24% Buy | 88% Sell | ||
| Last Month's Opinion | 64% Sell | 56% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.86% since 11/09/20 | -0.55% since 04/17/24 | +0.20% since 04/17/24 | ||
| Low | 15.10 on 11/10/20 | 70.71 on 04/19/24 | 24.14 on 04/22/24 | ||
| High | 16.15 on 11/16/20 | 72.23 on 04/22/24 | 26.26 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +0.92% since 10/16/20 | -3.48% since 03/22/24 | -15.38% since 03/22/24 | ||
| Low | 14.00 on 10/29/20 | 70.71 on 04/19/24 | 24.14 on 04/22/24 | ||
| High | 16.15 on 11/16/20 | 74.44 on 04/01/24 | 31.23 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | -2.07% since 08/14/20 | +0.82% since 01/24/24 | -30.93% since 01/24/24 | ||
| Low | 14.00 on 10/29/20 | 69.18 on 01/25/24 | 24.14 on 04/22/24 | ||
| High | 17.03 on 08/19/20 | 77.72 on 02/23/24 | 41.04 on 02/15/24 | ||
| 6-Month | |||||
| %Chg | +4.58% since 05/15/20 | +6.20% since 10/24/23 | -0.16% since 10/24/23 | ||
| Low | 14.00 on 10/29/20 | 63.72 on 11/03/23 | 24.12 on 10/25/23 | ||
| High | 19.24 on 06/08/20 | 77.72 on 02/23/24 | 44.32 on 12/28/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,586,212 | 11,930,109 | 4,476,683 | ||
| Shares Outstanding, K | 541,546 | 166,878 | 175,832 | ||
| Annual Sales | 11,500,500,000 | 2,992,000,000 | 9,300,000 | ||
| Annual Net Income | 16,800,000 | 548,000,000 | -643,200,000 | ||
| Last Quarter Sales | 2,972,100,000 | 865,780,000 | 1,750,000 | ||
| Last Quarter Net Income | 185,700,000 | 165,470,000 | -168,150,000 | ||
| 60-Month Beta | 1.45 | 0.58 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.36 on 11/06/20 | 0.99 on 01/31/24 | -0.96 on 02/22/24 | ||
| Latest Earnings Date | 11/06/20 | 05/08/24 | 05/02/24 | ||
| Most Recent Dividend | 0.060 on 06/27/07 | 0.410 on 07/28/23 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/28/23 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 3.29 | 19.04 | 0.00 | ||